RF Acquisition Corp II
Status: Live Deal
U=S+R
R=S/20
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | May 17, 2024 |
| CEO | Tse Meng Ng |
| Left Lead | EarlyBirdCapital |
| IPO Cash in Trust | 100.5% |
| SPAC Tenor | 18 months |
| IPO Sector | Technology ▶ |
| IPO Geography | Asia |
| Target Company | Nanyang Biologics |
| Deal Announced | Oct 2, 2025 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Nov 10, 2025 |
RFAI
RFAIU
RFAIR
| Price | $10.98 |
|---|---|
| Last closing price | $10.71 |
| H/L, today | $10.70 / $10.70 |
| Volume, today | 1,679 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.